The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors

The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors

ObjectiveRecently, immune checkpoint inhibitor (ICI) treatment has shown encouraging performance in improving the prognosis of hepatocellular carcinoma (HCC) patients. The gut microbiome plays a vital role in altering the efficacy of ICIs, which may be impacted by antibiotics. The aim of the meta-an...

Full description

Bibliographic Details
Main Authors: Lilong Zhang, Chen Chen, Dongqi Chai, Chunlei Li, Yongjun Guan, Li Liu, Tianrui Kuang, Wenhong Deng, Weixing Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
antibiotic
hepatocellular carcinoma
prognosis
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.956533/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.956533/full

Similar Items